PTGX Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-01-16 | Giraudo Bryan | director | 30,000 | A-Award | A | 30,000 | 12.17 | 365,100.00 |
| 2023-01-16 | Waddill William D. | director | 30,000 | A-Award | A | 30,000 | 12.17 | 365,100.00 |
| 2023-01-16 | Williams Lewis T | director | 30,000 | A-Award | A | 30,000 | 12.17 | 365,100.00 |
| 2023-01-16 | Noonberg Sarah B. | director | 30,000 | A-Award | A | 30,000 | 12.17 | 365,100.00 |
| 2023-01-16 | O'Dowd Sarah A | director | 30,000 | A-Award | A | 30,000 | 12.17 | 365,100.00 |
| 2023-01-16 | Ali Asif | officer: Chief Financial Officer | 63,750 | A-Award | A | 63,750 | 12.17 | 775,837.50 |
| 2023-01-16 | Ali Asif | officer: Chief Financial Officer | 24,375 | A-Award | A | 10,625 | 0.00 | 0.00 |
| 2023-01-16 | Gupta Suneel | officer: Chief Development Officer | 123,750 | A-Award | A | 123,750 | 12.17 | 1,506,037.50 |
| 2023-01-16 | Gupta Suneel | officer: Chief Development Officer | 138,187 | A-Award | A | 20,625 | 0.00 | 0.00 |
| 2023-01-16 | SELICK HAROLD E | director | 30,000 | A-Award | A | 30,000 | 12.17 | 365,100.00 |
| 2023-01-16 | MOLINA ARTURO MD | officer: Chief Medical Officer | 18,750 | A-Award | A | 18,750 | 12.17 | 228,187.50 |
| 2023-01-16 | MOLINA ARTURO MD | officer: Chief Medical Officer | 24,375 | A-Award | A | 3,125 | 0.00 | 0.00 |
| 2023-01-16 | PATEL DINESH V PH D | director, officer: President and CEO | 600,000 | A-Award | A | 600,000 | 12.17 | 7,302,000.00 |
| 2022-12-28 | PATEL DINESH V PH D | director, officer: President and CEO | 598,096 | G-Gift | D | 3,116 | 0.00 | 0.00 |
| 2022-11-16 | Liu David Y | officer: Chief R&D Strategy Officer | 0 | M-Exempt | D | 35,331 | 4.21 | 148,743.51 |
| 2022-11-16 | Liu David Y | officer: Chief R&D Strategy Officer | 167,590 | M-Exempt | A | 35,331 | 4.21 | 148,743.51 |
| 2022-11-16 | Liu David Y | officer: Chief R&D Strategy Officer | 132,259 | M-Exempt | A | 35,656 | 1.16 | 41,360.96 |
| 2022-11-16 | Liu David Y | officer: Chief R&D Strategy Officer | 96,603 | M-Exempt | A | 5,999 | 1.89 | 11,338.11 |
| 2022-11-16 | Liu David Y | officer: Chief R&D Strategy Officer | 90,604 | M-Exempt | A | 9,726 | 1.89 | 18,382.14 |
| 2022-11-16 | Liu David Y | officer: Chief R&D Strategy Officer | 80,878 | M-Exempt | A | 13,767 | 0.87 | 11,977.29 |
| 2022-11-15 | MOLINA ARTURO MD | officer: Chief Medical Officer | 127,500 | A-Award | A | 127,500 | 8.04 | 1,025,100.00 |
| 2022-11-15 | MOLINA ARTURO MD | officer: Chief Medical Officer | 21,250 | A-Award | A | 21,250 | 0.00 | 0.00 |
| 2022-08-23 | PATEL DINESH V PH D | director, officer: President and CEO | 60,000 | M-Exempt | D | 20,000 | 4.21 | 84,200.00 |
| 2022-08-23 | PATEL DINESH V PH D | director, officer: President and CEO | 604,048 | M-Exempt | A | 20,000 | 4.21 | 84,200.00 |
| 2022-05-26 | O'Dowd Sarah A | director | 20,000 | A-Award | A | 20,000 | 8.31 | 166,200.00 |
| 2022-05-26 | Waddill William D. | director | 20,000 | A-Award | A | 20,000 | 8.31 | 166,200.00 |
| 2022-05-26 | Williams Lewis T | director | 20,000 | A-Award | A | 20,000 | 8.31 | 166,200.00 |
| 2022-05-26 | Noonberg Sarah B. | director | 20,000 | A-Award | A | 20,000 | 8.31 | 166,200.00 |
| 2022-05-26 | Giraudo Bryan | director | 20,000 | A-Award | A | 20,000 | 8.31 | 166,200.00 |
| 2022-05-26 | SELICK HAROLD E | director | 20,000 | A-Award | A | 20,000 | 8.31 | 166,200.00 |
| 2022-05-04 | PATEL DINESH V PH D | director, officer: President and CEO | 581,048 | G-Gift | D | 3,000 | 0.00 | 0.00 |
| 2022-05-04 | PATEL DINESH V PH D | director, officer: President and CEO | 80,000 | M-Exempt | D | 15,742 | 4.21 | 66,273.82 |
| 2022-05-04 | PATEL DINESH V PH D | director, officer: President and CEO | 584,048 | M-Exempt | A | 15,742 | 4.21 | 66,273.82 |
| 2022-05-03 | Waddill William D. | director | 0 | M-Exempt | D | 12,000 | 8.59 | 103,080.00 |
| 2022-05-03 | Waddill William D. | director | 12,000 | M-Exempt | A | 12,000 | 8.59 | 103,080.00 |
| 2022-04-26 | Gupta Suneel | officer: Chief Development Officer | 70,000 | M-Exempt | D | 40,000 | 7.38 | 295,200.00 |
| 2022-04-26 | Gupta Suneel | officer: Chief Development Officer | 117,561 | M-Exempt | A | 40,000 | 7.38 | 295,200.00 |
| 2022-04-26 | PATEL DINESH V PH D | director, officer: President and CEO | 95,742 | M-Exempt | D | 30,000 | 4.21 | 126,300.00 |
| 2022-04-26 | PATEL DINESH V PH D | director, officer: President and CEO | 568,306 | M-Exempt | A | 30,000 | 4.21 | 126,300.00 |
| 2022-04-18 | Ali Asif | officer: Chief Financial Officer | 82,500 | A-Award | A | 82,500 | 19.19 | 1,583,175.00 |
| 2022-04-18 | Ali Asif | officer: Chief Financial Officer | 13,750 | A-Award | A | 13,750 | 0.00 | 0.00 |
| 2022-04-14 | PATEL DINESH V PH D | director, 10 percent owner, officer: President and CEO | 0 | M-Exempt | D | 34,087 | 1.89 | 64,424.43 |
| 2022-04-14 | PATEL DINESH V PH D | director, 10 percent owner, officer: President and CEO | 537,847 | M-Exempt | A | 34,087 | 1.89 | 64,424.43 |
| 2022-02-28 | Liu David Y | officer: Chief Scientific Officer | 66,538 | F-InKind | D | 2,119 | 24.28 | 51,449.32 |
| 2022-02-28 | PATEL DINESH V PH D | director, officer: President and CEO | 503,760 | F-InKind | D | 4,648 | 24.28 | 112,853.44 |
| 2022-02-28 | Gupta Suneel | officer: Chief Development Officer | 77,007 | F-InKind | D | 649 | 24.28 | 15,757.72 |
| 2022-02-15 | Kalkofen Donald A. | officer: Chief Financial Officer | 45,000 | A-Award | A | 45,000 | 28.73 | 1,292,850.00 |
| 2022-02-15 | Kalkofen Donald A. | officer: Chief Financial Officer | 18,521 | A-Award | A | 7,500 | 0.00 | 0.00 |
| 2022-02-15 | PATEL DINESH V PH D | director, officer: President and CEO | 187,500 | A-Award | A | 187,500 | 28.73 | 5,386,875.00 |
| 2022-02-15 | PATEL DINESH V PH D | director, officer: President and CEO | 508,408 | A-Award | A | 31,250 | 0.00 | 0.00 |
| 2022-02-15 | Gupta Suneel | officer: Chief Development Officer | 75,000 | A-Award | A | 75,000 | 28.73 | 2,154,750.00 |
| 2022-02-15 | Gupta Suneel | officer: Chief Development Officer | 77,656 | A-Award | A | 12,500 | 0.00 | 0.00 |
| 2022-02-15 | Liu David Y | officer: Chief Scientific Officer | 60,000 | A-Award | D | 60,000 | 28.73 | 1,723,800.00 |
| 2022-02-15 | Liu David Y | officer: Chief Scientific Officer | 68,657 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2021-12-21 | PATEL DINESH V PH D | director, officer: President and CEO | 477,158 | S-Sale | D | 15,000 | 32.14 | 482,170.50 |
| 2021-09-21 | PATEL DINESH V PH D | director, officer: President and CEO | 125,742 | M-Exempt | D | 40,000 | 4.21 | 168,400.00 |
| 2021-09-21 | PATEL DINESH V PH D | director, officer: President and CEO | 492,158 | M-Exempt | A | 40,000 | 4.21 | 168,400.00 |
| 2021-08-17 | Liu David Y | officer: Chief Scientific Officer | 73,033 | M-Exempt | A | 10,000 | 0.87 | 8,700.00 |
| 2021-08-17 | Liu David Y | officer: Chief Scientific Officer | 58,254 | S-Sale | D | 14,779 | 47.56 | 702,889.24 |
| 2021-08-17 | Liu David Y | officer: Chief Scientific Officer | 13,767 | M-Exempt | D | 10,000 | 0.87 | 8,700.00 |
| 2021-05-27 | SELICK HAROLD E | director | 18,000 | A-Award | A | 18,000 | 35.23 | 634,140.00 |
| 2021-05-27 | Noonberg Sarah B. | director | 18,000 | A-Award | A | 18,000 | 35.23 | 634,140.00 |
| 2021-05-27 | Giraudo Bryan | director | 18,000 | A-Award | A | 18,000 | 35.23 | 634,140.00 |
| 2021-05-27 | Waddill William D. | director | 18,000 | A-Award | A | 18,000 | 35.23 | 634,140.00 |
| 2021-05-27 | O'Dowd Sarah A | director | 18,000 | A-Award | A | 18,000 | 35.23 | 634,140.00 |
| 2021-05-27 | Williams Lewis T | director | 18,000 | A-Award | A | 18,000 | 35.23 | 634,140.00 |
| 2021-02-26 | Gupta Suneel | officer: Chief Development Officer | 63,987 | A-Award | A | 12,000 | 0.00 | 0.00 |
| 2021-02-26 | Gupta Suneel | officer: Chief Development Officer | 80,000 | A-Award | A | 80,000 | 0.00 | 0.00 |
| 2021-02-26 | Liu David Y | officer: Chief Scientific Officer | 62,427 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2021-02-26 | Liu David Y | officer: Chief Scientific Officer | 65,000 | A-Award | A | 65,000 | 23.57 | 1,532,050.00 |
| 2021-02-26 | PATEL DINESH V PH D | director, officer: President and CEO | 451,144 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2021-02-26 | PATEL DINESH V PH D | director, officer: President and CEO | 225,000 | A-Award | A | 225,000 | 23.57 | 5,303,250.00 |
| 2021-02-26 | Kalkofen Donald A. | officer: Chief Financial Officer | 10,386 | A-Award | A | 7,500 | 0.00 | 0.00 |
| 2021-02-26 | Kalkofen Donald A. | officer: Chief Financial Officer | 55,000 | A-Award | A | 55,000 | 23.57 | 1,296,350.00 |
| 2021-02-26 | Saks Samuel R | officer: Chief Medical Officer | 14,000 | A-Award | A | 12,000 | 0.00 | 0.00 |
| 2021-02-26 | Saks Samuel R | officer: Chief Medical Officer | 90,000 | A-Award | A | 90,000 | 23.57 | 2,121,300.00 |
| 2021-02-11 | Noonberg Sarah B. | director | 3,600 | M-Exempt | D | 3,700 | 25.09 | 92,833.00 |
| 2021-02-11 | Noonberg Sarah B. | director | 3,700 | A-Award | A | 3,700 | 25.09 | 92,833.00 |
| 2021-02-11 | Noonberg Sarah B. | director | 0 | S-Sale | D | 3,700 | 25.09 | 92,833.00 |
| 2021-02-10 | Noonberg Sarah B. | director | 4,700 | A-Award | A | 4,700 | 6.98 | 32,806.00 |
| 2021-02-10 | Noonberg Sarah B. | director | 7,300 | M-Exempt | D | 4,700 | 6.98 | 32,806.00 |
| 2021-02-10 | Noonberg Sarah B. | director | 400 | S-Sale | D | 4,300 | 25.42 | 109,306.00 |
| 2021-02-10 | Noonberg Sarah B. | director | 0 | S-Sale | D | 400 | 26.04 | 10,416.00 |
| 2021-01-19 | PATEL DINESH V PH D | director, officer: President and CEO | 426,144 | S-Sale | D | 24,846 | 24.60 | 611,104.76 |
| 2021-01-19 | PATEL DINESH V PH D | director, officer: President and CEO | 450,990 | M-Exempt | A | 13,000 | 4.21 | 54,730.00 |
| 2021-01-19 | PATEL DINESH V PH D | director, officer: President and CEO | 165,742 | M-Exempt | D | 13,000 | 4.21 | 54,730.00 |
| 2020-08-17 | O'Dowd Sarah A | director | 30,000 | A-Award | A | 30,000 | 16.50 | 495,000.00 |
| 2020-08-11 | KHOSLA CHAITAN PHD | director | 0 | S-Sale | D | 2,499 | 1.89 | 4,723.11 |
| 2020-08-11 | KHOSLA CHAITAN PHD | director | 7,499 | M-Exempt | D | 2,499 | 1.89 | 4,723.11 |
| 2020-08-11 | KHOSLA CHAITAN PHD | director | 2,499 | M-Exempt | A | 2,499 | 1.89 | 4,723.11 |
| 2020-05-28 | Giraudo Bryan | director | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2020-05-28 | KHOSLA CHAITAN PHD | director | 15,000 | A-Award | A | 15,000 | 16.54 | 248,100.00 |
| 2020-05-28 | Noonberg Sarah B. | director | 15,000 | A-Award | A | 15,000 | 16.54 | 248,100.00 |
| 2020-05-28 | SELICK HAROLD E | director | 15,000 | A-Award | A | 15,000 | 16.54 | 248,100.00 |
| 2020-05-28 | Waddill William D. | director | 15,000 | A-Award | A | 15,000 | 16.54 | 248,100.00 |
| 2020-05-28 | Williams Lewis T | director | 15,000 | A-Award | A | 15,000 | 16.54 | 248,100.00 |
| 2020-04-29 | PATEL DINESH V PH D | director, officer: President and CEO | 437,990 | G-Gift | D | 2,000 | 0.00 | 0.00 |
| 2020-03-20 | PATEL DINESH V PH D | director, officer: President and CEO | 439,990 | M-Exempt | A | 10,000 | 1.89 | 18,900.00 |
| 2020-03-20 | PATEL DINESH V PH D | director, officer: President and CEO | 34,087 | M-Exempt | D | 10,000 | 1.89 | 18,900.00 |
| 2020-03-12 | PATEL DINESH V PH D | director, officer: President and CEO | 429,990 | M-Exempt | A | 18,344 | 1.16 | 21,279.04 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.